Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study
Article 2020 en
Authors
AC
Anastasia Constantinidou
NS
Nicolas Sauvé
SS
Silvia Stacchiotti
Abstract
1 min read
The outcome of angiosarcoma patients treated with (neo)adjuvant chemotherapy in this case series compares favourably with previously published data. Due to the aggressive nature of angiosarcoma, a prospective trial of neoadjuvant chemotherapy should be considered.
Christian U. Blank, Judith M. Versluis, Elisa A. Rozeman, Alexander M. Menzies, Irene L. M. Reijers, Oscar Krijgsman, Esmée P. Hoefsmit, Bart A. van de Wiel, Karolina Sikorska, Carolien Bierman, Petros Dimitriadis, Maria Gonzalez, Annegien Broeks, Ron Kerkhoven, Andrew J. Spillane, John B.A.G. Haanen, Winan J. van Houdt, Robyn P.M. Saw, Hanna Eriksson, Alexander C.J. van Akkooi, Richard A Scolyer, Ton N. Schumacher, Georgina V. Long
Elisa A. Rozeman, Alexander Christopher Jonathan Van Akkooi, Émilie Routier, Alexander M. Menzies, Hanna Eriksson, Myles Smith, Richard A Scolyer, Christoph Höeller, Johan Hansson, Caroline Robert, James Larkin, Georgina V. Long, Christian U. Blank
Judith M. Versluis, E.A. Rozeman, AM Menzies, ILM Reijers, Oscar Krijgsman, EP Hoefsmit, BA van de Wiel, Karolina Sikorska, Carolien Bierman, Petros Dimitriadis, Maria Gonzalez, Annegien Broeks, RM Kerkhoven, Andrew J. Spillane, J.B.A.G. Haanen, W. van Houdt, Rpm Saw, Hanna Eriksson, Alexander C.J. van Akkooi, Richard A Scolyer, TN Schumacher,
Discussion(0)
No comments yet. Be the first to comment.